Stocks and Investing
Stocks and Investing
Thu, June 30, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Jonathan Petersen Maintained (DOC) at Strong Buy with Decreased Target to $20 on, Jun 30th, 2022
Jonathan Petersen of Jefferies, Maintained "Healthpeak Properties, Inc." (DOC) at Strong Buy with Decreased Target from $21 to $20 on, Jun 30th, 2022.
Jonathan has made no other calls on DOC in the last 4 months.
There are 4 other peers that have a rating on DOC. Out of the 4 peers that are also analyzing DOC, 2 agree with Jonathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Richard Hill of "Morgan Stanley" Maintained at Hold and Held Target at $18 on, Wednesday, June 1st, 2022
- Michael Carroll of "RBC Capital" Maintained at Hold with Increased Target to $19 on, Friday, May 20th, 2022
These are the ratings of the 2 analyists that currently disagree with Jonathan
- Joshua Dennerlein of "B of A Securities" Downgraded from Hold to Sell and Held Target at $18 on, Thursday, May 19th, 2022
- Steve Valiquette of "Barclays" Initiated at Buy and Held Target at $20 on, Tuesday, April 26th, 2022
Contributing Sources